Skip to main content
Clinical Trials/ISRCTN32694665
ISRCTN32694665
Completed
Not Applicable

Intra-articular injection of hyaluronic acid (MW 1500-2000 KDa; HyalOne®) in symptomatic osteoarthritis of the hip: a prospective cohort study

Fidia Farmaceutici S.p.A (Italy)0 sites304 target enrollmentMay 20, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patients suffering from hip osteoarthritis
Sponsor
Fidia Farmaceutici S.p.A (Italy)
Enrollment
304
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 20, 2010
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Fidia Farmaceutici S.p.A (Italy)

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \> 40 years
  • 2\. Hip OA with joint pain of at least one year?s duration
  • 2\.1\. Symptomatic hip OA according to the American College of Rheumatology (ACR)
  • 2\.2\. Grade I, II, III or IV hip OA according to the Kellgren\-Lawrence classification
  • 2\.3\. Evaluated on an X\-ray taken no more than two months before enrolment

Exclusion Criteria

  • 1\. Concomitant use of oral anticoagulant therapy
  • 2\. Severe reduction of joint space narrowing evident on X\-ray
  • 3\. Significant co\-morbidities, hypersensitivity to HA or to avian proteins
  • 4\. Chronic systemic steroid treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials